The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

biodol.eu

Founded Year

2015

Stage

Series A | Alive

Total Raised

$5.38M

Last Raised

$5.38M | 2 yrs ago

About Biodol Therapeutics

Biodol Therapeutics develops first-in-class compounds for the treatment of chronic neuropathic pain.

Biodol Therapeutics Headquarter Location

Cap Alpha - Av. de l’Europe

Jacou, 34830,

France

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Biodol Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biodol Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Biodol Therapeutics Patents

Biodol Therapeutics has filed 2 patents.

The 3 most popular patent topics include:

  • Analgesics
  • Clusters of differentiation
  • G protein coupled receptors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/8/2017

7/14/2020

Analgesics, Clusters of differentiation, G protein coupled receptors, Hepatotoxins, Transcription factors

Grant

Application Date

6/8/2017

Grant Date

7/14/2020

Title

Related Topics

Analgesics, Clusters of differentiation, G protein coupled receptors, Hepatotoxins, Transcription factors

Status

Grant

Latest Biodol Therapeutics News

Biodol Therapeutics s’oppose à la douleur

Sep 7, 2020

PAR ANNE JOLY | 429 mots Même pas mal ! Fondé en 2015 pour s’attaquer au sujet épineux de la douleur, Biodol Therapeutics réunit un tour de financement de série A afin de poursuivre ses essais pré-cliniques pour identifier un candidat médicament susceptible de venir à bout des douleurs neuropathiques chroniques. Le VC belge V-Bio Ventures a participé pour plusieurs millions en equity tandis que Bpifrance continue à épauler la société qui a déjà reçu quelque 2 M€ d’aides, avances et subventions depuis sa création. Installée à Montpellier et Strasbourg, la biotech s’appuie sur les travaux de Jean Valmier (professeur à ...

  • When was Biodol Therapeutics founded?

    Biodol Therapeutics was founded in 2015.

  • Where is Biodol Therapeutics's headquarters?

    Biodol Therapeutics's headquarters is located at Cap Alpha - Av. de l’Europe, Jacou.

  • What is Biodol Therapeutics's latest funding round?

    Biodol Therapeutics's latest funding round is Series A.

  • How much did Biodol Therapeutics raise?

    Biodol Therapeutics raised a total of $5.38M.

  • Who are the investors of Biodol Therapeutics?

    Investors of Biodol Therapeutics include V-Bio Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.